Insiders · SXTC

SXTC insider transactions

China SXT Pharmaceuticals Inc. (SXTC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

SXTC insiders

Everyone who has filed a Form 3, 4, 5 or 144 at China SXT Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.

• Xiaodong Sean PanChief Financial Officer, since January 2022
• Xiaodong JiDirector, since May 2021
• Tong Tony LiuDirector, since May 2022
• Yong Lip CheeDirector, since January 2025
• Feng Felix ZhouCo-CEO and Director, since July 2017
• Simon Lim Sze BengCo-Chief Executive Officer, since January 2025
• Jun ZhengDirector, since December 2018

Recent Form 3, 4, and 5 filings for SXTC

• 196d
  SEC Form 3 filed by new insider Pan Xiaodong Sean

  3 - China SXT Pharmaceuticals, Inc. (0001723980) (Issuer)
• 196d
  SEC Form 3 filed by new insider Liu Tong Tony

  3 - China SXT Pharmaceuticals, Inc. (0001723980) (Issuer)
• 196d
  SEC Form 3 filed by new insider Ji Xiaodong

  3 - China SXT Pharmaceuticals, Inc. (0001723980) (Issuer)
• 196d
  New insider Zhou Feng Felix claimed ownership of 4 units of Class B Ordinary Shares (SEC Form 3)

  3 - China SXT Pharmaceuticals, Inc. (0001723980) (Issuer)
• 196d
  SEC Form 3 filed by new insider Chee Yong Lip

  3 - China SXT Pharmaceuticals, Inc. (0001723980) (Issuer)
• 196d
  SEC Form 3 filed by new insider Simon Lim Sze Beng

  3 - China SXT Pharmaceuticals, Inc. (0001723980) (Issuer)
• 196d
  SEC Form 3 filed by new insider Zheng Jun

  3 - China SXT Pharmaceuticals, Inc. (0001723980) (Issuer)